Two Case Studies on Inferior Mesenteric Artery Embolization for Primary Postpartum Hemorrhage

por Kawakami, Naoki, Uchiyama, Fumiya, Harada, Akinori, Yamada, Tetsuhisa, Nishimura, Jun-ichi
Publicado 2022

The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria

por Kulasekararaj, Austin G., Brodsky, Robert A., Nishimura, Jun-ichi, Patriquin, Christopher J., Schrezenmeier, Hubert
Publicado 2022

P781: EVALUATION OF PEGCETACOPLAN TREATMENT SUCCESS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH AND WITHOUT BONE MARROW FAILURE: A MOVE TOWARDS INDIVIDUALIZED PATIENT TREATMENT

por Szer, Jeff, Panse, Jens, Kulasekararaj, Austin, Oliver, Monika, Fattizzo, Bruno, Nishimura, Jun-Ichi, Szamosi, Johan, Horneff, Regina, Peffault de Latour, Régis
Publicado 2023

Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies

por Kulasekararaj, Austin G., Griffin, Morag, Langemeijer, Saskia, Usuki, Kensuke, Kulagin, Alexander, Ogawa, Masayo, Yu, Ji, Mujeebuddin, Arshad, Nishimura, Jun‐ichi, Lee, Jong Wook, Peffault de Latour, Régis
Publicado 2022

P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE...

por Kulasekararaj, Austin, Brodsky, Robert, Griffin, Morag, Röth, Alexander, Piatek, Caroline, Ogawa, Masayo, Yu, Ji, Patel, Yogesh, Fernandez, Fernando Ataulfo Gonzalez, Nishimura, Jun-Ichi, Peffault de Latour, Régis, Szer, Jeff, Wook Lee, Jong
Publicado 2023

Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports

por Ito, Yu, Awano, Nobuyasu, Uchiyama, Fumiya, Inomata, Minoru, Kuse, Naoyuki, Tone, Mari, Takada, Kohei, Fujimoto, Kazushi, Muto, Yutaka, Sagisaka, Shogo, Maki, Kenro, Yamashita, Ryuta, Harada, Akinori, Nishimura, Jun-ichi, Hayashi, Munehiro, Izumo, Takehiro
Publicado 2021

S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPL...

por Röth, Alexander, He, Guangsheng, Brodsky, Andres, Chai-Adisaksopha, Chatree Chatree, Dumagay, Teresita, Demichelis, Roberta, Höglund, Martin, Kelly, Richard, Lee, Je-Hwan, Nishimura, Jun-Ichi, Obara, Naoshi, Risitano, Antonio Maria, Gaya, Anna, Appius, Anita, Gentile, Brittany, Negricea, Raluca, Zhang, Zilu, Buatois, Simon, Han, Bing
Publicado 2023

P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY

por Röth, Alexander, Berentsen, Sigbjørn, Barcellini, Wilma, D’sa, Shirley, Jilma, Bernd, Michel, Marc, Weitz, Ilene C, Yamaguchi, Masaki, Nishimura, Jun-Ichi, Vos, Josephine, Cid, Joan, Storek, Michael, Wong, Nancy, Yoo, Ronnie, Jayawardene, Deepthi, Srivastava, Shruti, Wardęcki, Marek, Shafer, Frank, Lee, Michelle, Broome, Catherine M
Publicado 2023

P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA S...

por Röth, Alexander, Berentsen, Sigbjørn, Barcellini, Wilma, D’sa, Shirley, Jilma, Bernd, Michel, Marc, Weitz, Ilene C, Yamaguchi, Masaki, Nishimura, Jun-Ichi, Vos, Josephine, Cid, Joan, Storek, Michael, Wong, Nancy, Yoo, Ronnie, Jayawardene, Deepthi, Kralova, Katarina, Wardęcki, Marek, Shafer, Frank, Lee, Michelle, Broome, Catherine M
Publicado 2023

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial

por Röth, Alexander, Berentsen, Sigbjørn, Barcellini, Wilma, D’Sa, Shirley, Jilma, Bernd, Michel, Marc, Weitz, Ilene C., Yamaguchi, Masaki, Nishimura, Jun-ichi, Vos, Josephine M. I., Storek, Michael, Wong, Nancy, Patel, Parija, Jiang, Xiaoyu, Vagge, Deepthi S., Wardęcki, Marek, Shafer, Frank, Lee, Michelle, Broome, Catherine M.
Publicado 2022

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria

por Nishimura, Jun-ichi, Ando, Kiyoshi, Masuko, Masayoshi, Noji, Hideyoshi, Ito, Yoshikazu, Mayer, Jiri, Griskevicius, Laimonas, Bucher, Christoph, Müllershausen, Florian, Gergely, Peter, Rozenberg, Izabela, Schubart, Anna, Chawla, Raghav, Rondeau, Jean-Michel, Roguska, Michael, Splawski, Igor, Keating, Mark T., Johnson, Leslie, Danekula, Rambabu, Bagger, Morten, Watanabe, Yoko, Haraldsson, Börje, Kanakura, Yuzuru
Publicado 2021